Keep the record within reach
A source has a scope.
The document behind a claim matters. A provider’s offer describes an advertised service; a drug label and a clinical guidance page answer different questions. Each record below links back to the reading that uses it.
Accessed 2026-09-27
CoreAge Rx Smooth Move product page
Provider product description; commercial claims
Read the original sourceArticles using this source
- CoreAge Rx Smooth Move after 50: the questions beyond the offer
- Tretinoin options after 50: compare the care questions first
- Starting the tretinoin conversation after 50: what an expectation should include
- The other products belong in a tretinoin conversation after 50
- A long tretinoin plan needs more than a monthly price
Accessed 2026-09-27
CoreAge Rx Smooth Move current offer
Public sales landing page; offer and service statements
Read the original sourceArticles using this source
Accessed 2026-09-27
FDA: Compounding and the FDA: Questions and Answers
Federal regulatory explanation; not a provider compliance determination
Read the original sourceArticles using this source
- CoreAge Rx Smooth Move after 50: the questions beyond the offer
- Tretinoin options after 50: compare the care questions first
- Dermatica tretinoin after 50: formula promises and follow-up questions
- Musely tretinoin after 50: the cream, consultation and guarantee records
- Starting the tretinoin conversation after 50: what an expectation should include
- A long tretinoin plan needs more than a monthly price
Accessed 2026-09-27
AAD: Caring for your skin in menopause
Professional society patient guidance; general menopausal skin context
Read the original sourceArticles using this source
- CoreAge Rx Smooth Move after 50: the questions beyond the offer
- Tretinoin options after 50: compare the care questions first
- Dermatica tretinoin after 50: formula promises and follow-up questions
- Musely tretinoin after 50: the cream, consultation and guarantee records
- Starting the tretinoin conversation after 50: what an expectation should include
- Dryness after 50 and a new skin reaction are different questions
- The other products belong in a tretinoin conversation after 50
Accessed 2026-09-27
AAD: Rash 101: When to seek medical treatment
Professional society patient guidance; rash warning features
Read the original sourceArticles using this source
- CoreAge Rx Smooth Move after 50: the questions beyond the offer
- Tretinoin options after 50: compare the care questions first
- Dermatica tretinoin after 50: formula promises and follow-up questions
- Musely tretinoin after 50: the cream, consultation and guarantee records
- Dryness after 50 and a new skin reaction are different questions
Accessed 2026-09-27
DailyMed: RENOVA tretinoin cream 0.02%
Exact FDA-approved product labeling; record updated February 24, 2026; internal revision November 2025
Read the original sourceArticles using this source
- CoreAge Rx Smooth Move after 50: the questions beyond the offer
- Tretinoin options after 50: compare the care questions first
- Dermatica tretinoin after 50: formula promises and follow-up questions
- Musely tretinoin after 50: the cream, consultation and guarantee records
- Starting the tretinoin conversation after 50: what an expectation should include
- Dryness after 50 and a new skin reaction are different questions
- The other products belong in a tretinoin conversation after 50
- A long tretinoin plan needs more than a monthly price
Accessed 2026-09-27
Dermatica: Anti-aging personalized treatment
Provider treatment page; ingredient menu and service claims
Read the original sourceArticles using this source
Accessed 2026-09-27
Dermatica: Pricing
Provider plan and delivery terms
Read the original sourceArticles using this source
Accessed 2026-09-27
Dermatica US homepage
Provider homepage; compounded formulation and trial offer
Read the original sourceArticles using this source
Accessed 2026-09-27
Dermatica: Terms and conditions
Provider terms; page states last revised February 4, 2019, checked currently
Read the original sourceArticles using this source
Accessed 2026-09-27
Musely: The Anti-Aging Cream
Provider product, current offer and self-reported outcome claims
Read the original sourceArticles using this source
Accessed 2026-09-27
Musely: What are the formulas of The Anti-Aging Cream?
Provider formula FAQ; marketed options, not personal selection criteria
Read the original sourceArticles using this source
Accessed 2026-09-27
Musely: Ingredients in Musely Treatments
Provider ingredient record; exact Anti-Aging Cream section
Read the original sourceArticles using this source
Accessed 2026-09-27
Musely: Breakdown of Doctor Visit Fees — What is the fee for?
Provider consultation, prescription and nonrefundability terms
Read the original sourceArticles using this source
Accessed 2026-09-27
Musely: What is the 60-Day Result Guarantee?
Provider reimbursement conditions; not clinical efficacy evidence
Read the original sourceArticles using this source
Accessed 2026-09-27
American Academy of Dermatology: retinoid and retinol
Professional society guidance, updated May 25, 2021; irritation and professional-assessment context
Read the original sourceArticles using this source
Accessed 2026-09-27
American Academy of Dermatology: how to exfoliate at home
Professional society public guidance, updated February 6, 2026; existing-product and irritation cautions, no routine transfer
Read the original sourceArticles using this source
Accessed 2026-09-27
FDA pharmacists help you use medicines safely
Federal regulator consumer resource; product lists, history and conflicting information
Read the original source